• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于机器学习和综合生物信息学的胃癌生物标志物候选物鉴定:迈向个体化医疗。

Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine.

机构信息

Department for Bioinformatics, School of Life Sciences, Pondicherry University, Puducherry, India.

出版信息

OMICS. 2023 Jun;27(6):260-272. doi: 10.1089/omi.2023.0015. Epub 2023 May 25.

DOI:10.1089/omi.2023.0015
PMID:37229622
Abstract

Gastric cancer (GC) is among the leading causes of cancer-related deaths worldwide. The discovery of robust diagnostic biomarkers for GC remains a challenge. This study sought to identify biomarker candidates for GC by integrating machine learning (ML) and bioinformatics approaches. Transcriptome profiles of patients with GC were analyzed to identify differentially expressed genes between the tumor and adjacent normal tissues. Subsequently, we constructed protein-protein interaction networks so as to find the significant hub genes. Along with the bioinformatics integration of ML methods such as support vector machine, the recursive feature elimination was used to select the most informative genes. The analysis unraveled 160 significant genes, with 88 upregulated and 72 downregulated, 10 hub genes, and 12 features from the variable selection method. The integrated analyses found that , , , and genes are significant and poised as potential diagnostic biomarkers in relation to GC. The receiver operating characteristic curve analysis found and are strongly associated with diagnosis of GC. We suggest and are considered as biomarker candidates that might potentially inform future research on diagnosis, prognosis, or therapeutic targets for GC. These findings collectively offer new future possibilities for precision/personalized medicine research and development for patients with GC.

摘要

胃癌(GC)是全球癌症相关死亡的主要原因之一。发现稳健的 GC 诊断生物标志物仍然是一个挑战。本研究旨在通过整合机器学习(ML)和生物信息学方法来鉴定 GC 的生物标志物候选物。分析 GC 患者的转录组谱,以鉴定肿瘤与相邻正常组织之间的差异表达基因。随后,我们构建了蛋白质-蛋白质相互作用网络,以找到重要的枢纽基因。通过支持向量机等 ML 方法的生物信息学整合,递归特征消除用于选择最具信息量的基因。分析揭示了 160 个显著基因,其中 88 个上调,72 个下调,10 个枢纽基因和 12 个来自变量选择方法的特征。综合分析发现 、 、 和 基因与 GC 相关,是潜在的诊断生物标志物。受试者工作特征曲线分析发现 和 与 GC 的诊断密切相关。我们建议将 和 视为生物标志物候选物,这可能为未来 GC 的诊断、预后或治疗靶点的研究提供新的可能性。这些发现为 GC 患者的精准/个性化医学研究和开发提供了新的未来可能性。

相似文献

1
Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine.基于机器学习和综合生物信息学的胃癌生物标志物候选物鉴定:迈向个体化医疗。
OMICS. 2023 Jun;27(6):260-272. doi: 10.1089/omi.2023.0015. Epub 2023 May 25.
2
Machine Learning Identify Ferroptosis-Related Genes as Potential Diagnostic Biomarkers for Gastric Intestinal Metaplasia.机器学习鉴定铁死亡相关基因作为胃肠化生潜在的诊断生物标志物。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241272036. doi: 10.1177/15330338241272036.
3
Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.通过整合生物信息学分析和机器学习方法鉴定与肿瘤浸润免疫细胞和 ECM 动态相关的枢纽基因作为胃癌的潜在治疗靶点。
Comb Chem High Throughput Screen. 2023;26(4):653-667. doi: 10.2174/1386207325666220820163319.
4
Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.基于生物信息学分析鉴定与胃癌预后相关的潜在生物标志物。
Med Sci Monit. 2021 Feb 14;27:e929104. doi: 10.12659/MSM.929104.
5
Bioinformatics Prediction and Machine Learning on Gene Expression Data Identifies Novel Gene Candidates in Gastric Cancer.基于基因表达数据的生物信息学预测和机器学习鉴定胃癌新的候选基因。
Genes (Basel). 2022 Nov 28;13(12):2233. doi: 10.3390/genes13122233.
6
Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.胃癌差异表达基因及信号通路的综合生物信息学分析。
Int J Med Sci. 2021 Jan 1;18(3):792-800. doi: 10.7150/ijms.47339. eCollection 2021.
7
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.整合生物信息学分析揭示胃癌中新型关键生物标志物和潜在候选小分子药物。
Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
8
Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.整合转录组学、细胞实验和临床验证,鉴定 ILF2 作为胃癌的诊断血清生物标志物和治疗靶点。
BMC Cancer. 2024 Apr 15;24(1):465. doi: 10.1186/s12885-024-12175-z.
9
Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer.生物信息学分析和验证与胃癌预测和预后相关的潜在标志物。
Int J Mol Sci. 2024 May 28;25(11):5880. doi: 10.3390/ijms25115880.
10
Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.微阵列分析鉴定出 ETS1 是受 miR-23b 调控的潜在生物标志物,并调节胃癌中的 TCF4。
World J Surg Oncol. 2021 Oct 23;19(1):311. doi: 10.1186/s12957-021-02417-w.

引用本文的文献

1
Multi-omics analysis of Helicobacter pylori-associated gastric cancer identifies hub genes as a novel therapeutic biomarker.幽门螺杆菌相关胃癌的多组学分析确定枢纽基因为新型治疗生物标志物。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf241.